BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22570344)

  • 1. Differential expression of fourteen proteins between uveal melanoma from patients who subsequently developed distant metastases versus those who did Not.
    Linge A; Kennedy S; O'Flynn D; Beatty S; Moriarty P; Henry M; Clynes M; Larkin A; Meleady P
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4634-43. PubMed ID: 22570344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.
    Coupland SE; Vorum H; Mandal N; Kalirai H; Honoré B; Urbak SF; Lake SL; Dopierala J; Damato B
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):12-20. PubMed ID: 19643972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
    Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
    Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma inhibitory activity: a novel serum marker for uveal melanoma.
    Schaller UC; Bosserhoff AK; Neubauer AS; Buettner R; Kampik A; Mueller AJ
    Melanoma Res; 2002 Dec; 12(6):593-9. PubMed ID: 12459649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in uveal melanoma.
    Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
    Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis inhibitor, survivin, in posterior uveal melanoma: comparison among primary tumors, tumors resistant to brachytherapy, tumors with liver metastases, and liver metastases.
    Ben Simon GJ; Abulafia A; Pe'er J
    Curr Eye Res; 2006 Mar; 31(3):251-7. PubMed ID: 16531282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible implications of MCAM expression in metastasis and non-metastatic of primary uveal melanoma patients.
    Beutel J; Wegner J; Wegner R; Ziemssen F; Nassar K; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
    Curr Eye Res; 2009 Nov; 34(11):1004-9. PubMed ID: 19958117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of a role of the expression of a transmembranous CD117/C-Kit receptor in the progression of uveal melanomas].
    Anurova OA; Likhvantseva VG; Vereshchagina MV
    Vestn Oftalmol; 2007; 123(5):41-4. PubMed ID: 18078058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
    Scala S; Ieranò C; Ottaiano A; Franco R; La Mura A; Liguori G; Mascolo M; Staibano S; Ascierto PA; Botti G; De Rosa G; Castello G
    Cancer Immunol Immunother; 2007 Oct; 56(10):1589-95. PubMed ID: 17410362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.
    Laurent C; Valet F; Planque N; Silveri L; Maacha S; Anezo O; Hupe P; Plancher C; Reyes C; Albaud B; Rapinat A; Gentien D; Couturier J; Sastre-Garau X; Desjardins L; Thiery JP; Roman-Roman S; Asselain B; Barillot E; Piperno-Neumann S; Saule S
    Cancer Res; 2011 Feb; 71(3):666-74. PubMed ID: 21135111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.